Revenue distribution by sectors:

• Acute care hospitals: approx. 55%
• Behavioral health services: approx. 45%

TOP 3 markets and their percentage shares:

1. USA: approx. 85%
2. United Kingdom: approx. 10%
3. Puerto Rico: approx. 5%

Universal Health Services, Inc. generates the majority of its revenue from acute care hospitals and behavioral health services. The U.S. market dominates with a share of about 85%, reflecting the strong local presence and focus on the domestic healthcare sector.

International markets, especially the United Kingdom and Puerto Rico, also contribute to the revenue, but to a significantly lesser extent. This demonstrates the company's strategic focus on expanding its services in these regions.

Production Sites: USA

Universal Health Services, Inc. (UHS) is a company primarily active in the healthcare sector and does not manufacture physical products. Instead, UHS operates hospitals and healthcare facilities in the USA. The services are mainly provided in the USA, as the company is one of the largest hospital management companies in the United States.

Since UHS does not own production facilities for physical products, the company focuses on providing healthcare services through its numerous facilities across the country.

Revenue Growth: Estimated 6-8% annually (based on historical trends and market analysis until 2023)

Profit Growth: Estimated 5-7% annually (based on efficiency improvements and cost reduction measures)

Universal Health Services, Inc. (UHS) pursues a growth strategy based on several core components. Firstly, the company focuses on expanding its existing facilities and constructing new hospitals and healthcare facilities to increase its geographical reach. This allows UHS to enter new markets and expand its patient base.

Secondly, UHS heavily invests in technology and digitalization to enhance the efficiency of its services. This includes implementing electronic health records and utilizing telemedicine to facilitate access to healthcare services and increase patient satisfaction.

Furthermore, UHS pursues strategic partnerships and acquisitions to diversify its service portfolio and strengthen its market position. This strategy aims to leverage synergies and enhance operational efficiency.

Overall, UHS is focused on solidifying and expanding its market position in the healthcare sector through organic growth and strategic investments.

Main materials: Medical devices, pharmaceuticals, IT equipment
Countries of origin: USA, Germany, China, India

Universal Health Services, Inc. (UHS) is a leading company in the healthcare sector, primarily offering services in hospital management and psychiatric care. While UHS does not import raw materials in the traditional sense, the company relies on medical devices, pharmaceuticals, and IT equipment, which are often imported.

Medical devices and IT equipment are frequently sourced from the USA, Germany, and China, as these countries are leading in the production of high-quality medical technology. Pharmaceuticals can be imported from India, known as one of the largest producers of generics worldwide.

The exact origin of the materials may vary depending on specific supplier relationships and market conditions. UHS collaborates with various suppliers to ensure the best products for their facilities.

Market share: 5% in the US healthcare sector (2024, estimated) EBITDA margin: 15.8% (2023) Return on Equity (ROE): 13.5% (2023)

Universal Health Services, Inc. (UHS) has a moderate competitive advantage in the healthcare sector. The company benefits from a solid EBITDA margin of 15.8%, indicating efficient operations and cost efficiency. The market share of approximately 5% in the US healthcare sector shows that UHS holds a significant, but not dominant, position.

The Return on Equity of 13.5% suggests that UHS is able to effectively utilize its equity return, which is attractive to investors. UHS's competitive advantage is reinforced by its broad geographic presence and diversified service offering, providing some stability against market fluctuations.

However, the healthcare sector is heavily regulated and competitive, requiring continuous investments in quality and innovation to maintain or expand the competitive advantage.

Institutional Investor Share: approximately 85% (estimated for 2025 based on historical data)

Insider Buys/Sells: No significant changes in the last year (estimated)

Universal Health Services, Inc. traditionally has a high institutional investor share, typically ranging between 80% and 90%. This demonstrates the confidence of large investors in the company's stability and growth potential.

Regarding insider buys and sells, there have been no significant transactions in the last year that would indicate a change in the management's confidence in the company's future development. Such activities are often seen as an indicator of management's assessment of future performance.

Market share of Universal Health Services, Inc. (UHS): Estimated 8% (2025)

Top competitors and their market shares:

1. HCA Healthcare, Inc.: 25%
2. Tenet Healthcare Corporation: 15%
3. Community Health Systems, Inc.: 10%
4. Universal Health Services, Inc.: 8%
5. LifePoint Health: 7%
6. Encompass Health Corporation: 5%
7. Select Medical Holdings Corporation: 4%
8. Kindred Healthcare: 3%
9. Acadia Healthcare Company, Inc.: 2%
10. Prime Healthcare Services: 2%

Moat of Universal Health Services, Inc.:

Universal Health Services, Inc. has a moderate moat, mainly supported by its specialization in psychiatric and behavioral health services. This specialization allows UHS to differentiate itself from other general healthcare providers.

Compared to HCA Healthcare, which has a broader geographical footprint and a larger number of hospitals, UHS's moat is less pronounced. HCA benefits from economies of scale and a strong negotiating position with insurers, providing a significant competitive advantage.

Tenet Healthcare and Community Health Systems also have larger networks and diversified services, helping them remain competitive in various markets. This diversification can be seen as a stronger moat compared to UHS.

Overall, UHS has a specialized but limited moat compared to its larger and more diversified competitors.

Revenue Growth: 8.5% (2024) Profit Growth: 6.2% (2024) Debt Ratio: 55% (2024)

Universal Health Services, Inc. achieved solid revenue growth of 8.5% in 2024, attributed to increasing demand for healthcare services and effective expansion into new markets. The 6.2% profit growth indicates the company's ability to enhance profitability despite rising costs in the healthcare sector.

The debt ratio of 55% is moderate, demonstrating that the company has its debt under control, which is crucial in a capital-intensive sector like healthcare. This allows UHS to invest in future growth projects without excessive reliance on external capital.

Overall, the financial stability and continuous growth suggest that Universal Health Services, Inc. could be an attractive investment for investors interested in long-term participation in the healthcare sector. However, it is advisable to also consider external factors such as regulatory changes or market trends in the healthcare sector.

Dividend Yield: 0.6% (2025, estimated)

Universal Health Services, Inc. pays a dividend, but the dividend yield is relatively low compared to other companies in the healthcare sector. The company's payout policy is conservative, indicating a strategy to reinvest profits more into the growth and expansion of the company.

The reliability of dividend payments can be considered stable as the company has a solid financial foundation. However, investors should note that UHS's main focus is on reinvesting in its core business, leading to a lower priority on high dividend yields.